Switzerland: Appropriate time for Lonza Group to exit capsules business could be nearing
Bloomberg is reporting that Lonza Group, one of the world’s largest healthcare manufacturing organizations, has appointed Bank of America and Centerview Partners its capsules...
Germany: Merck to acquire SpringWorks Therapeutics to accelerate growth of Healthcare business
DAX-listed Merck, a Germany-based global science and technology company, is acquiring Nasdaq-listed SpringWorks Therapeutics, a commercial-stage biopharmaceutical company focused on severe rare diseases and...
Slovenia: Anjac Group takes step forward as CDMO with acquisition of Health Chain Group
Anjac Health & Beauty, a French family-owned industrial group specialising in the formulation, manufacturing and filling of cosmetics, medical devices, drugs, and food supplements,...
Spain: Antares becomes part of Evidenze to reinforce healthcare consulting capabilities
Antares Consulting has been acquired by Evidenze Group, reinforcing Evidenze's healthcare consulting capabilities as a new entity: Antares Evidenze Health Consulting.
Antares Consulting is the...
France: PLG appoints James Burt as CEO
ProductLife Group (PLG), a European provider of outsourced development, regulatory and compliance services to the global life sciences industry, has appointed Dr James Burt...
Germany: Sanner Group appoints Dirk Scholz as new CFO
Dirk Scholz has taken up his new role as CFO of the Sanner Group, a Germany-based global healthcare packaging and medical device CDMO. He succeeds...
Germany: Fresenius establishes €200m-plus venture fund to drive healthcare innovation
Fresenius, a Germany-based global, therapy-focused healthcare company, is expanding its access to innovation networks through Fresenius Ventures, its own corporate venture capital fund that...
Sweden: Calliditas increases and extends loan
Nasdaq and Nasdaq Stockholm-listed Calliditas Therapeutics, a specialty pharmaceutical company developing high value products, has signed and fully drawn a 9% fixed-rate term loan...
UK: Morgan Stanley appoints Mufti to co-head EMEA Healthcare Investment Banking role
Obaid Mufti has announced on LinkedIn his promotion to co-head of EMEA Healthcare Investment Banking at Morgan Stanley in London.
The long time Morgan Stanley...
Cell & Gene Therapies: The next big opportunity in pharma services
Cell and Gene therapies are an exciting novel class of pharmaceuticals, and an area where pharma services including CDMOs are likely to play a...
Advertisement
